Table 1.
Drug class | Compound/organisma | Chemistry | Pharmacologic activity | MMOAb | Countryc | References |
---|---|---|---|---|---|---|
Antibacterial | Acetylenic acid/sponge | Fatty acidd | Gram-positive and negative inhibition | Undetermined | JPN, NETH | Matsunaga et al., 2000 |
Antibacterial | Discorhabdin R/sponge | Alkaloidf | Gram-positive and negative inhibition | Undetermined | AUS | Ford and Capon et al. 2000 |
Anticoagulant | Fucoidan/alga | Sulfated Polysaccharideg | Inhibition of microvascular thrombus | No effect on P- and L-selectin | SWE, GER | Thorlacius et al., 2000 |
Anticoagulant | Proteoglycan/alga | Polysaccharideg | Anticoagulant | Inhibition of thrombin and potentiation of antithrombin III | JPN | Matsubara, 2000 |
Anticoagulant | Sulfated D-galactan/alga | Sulfated Polysaccharideg | Anticoagulant | Inhibition of thrombin and factor Xa | BRA | Farias et al., 2000 |
Antifungal | Lyngbyabellin B/bacterium | Depsipeptidef | C. albicans inhibition | Undetermined | USA | Milligan et al., 2000 |
Antifungal | Naamine D/sponge | Alkaloidf | C. neoformans inhibition | Nitric oxide inhibition | USA, NZ | Dunbar et al., 2000 |
Antimalarial | Ascosalipyrrolidinone A/fungus | Polyketided | P. falciparum inhibition | p56lck tryrosine kinase inhibition | GER, SWI | Osterhage et al., 2000 |
Antimalarial | Homofascaplysin A & fascaplysin/sponge | Sesterterpenee | P. falciparum inhibition | Undetermined | GER, SWZ | Kirsch et al., 2000 |
Antimalarial | Manzamine A/sponge | Alkaloidf | In vivo P. berghei inhibition | Undetermined | SING, JPN, USA | Ang et al., 2000 |
Antiplatelet | Eryloside F/sponge | Sterol glycosidee | Platelet aggregation inhibition | Thrombin receptor antagonist | USA, UK | Stead et al., 2000 |
Antituberculosis | Axisonitrile-3/sponge | Sesquiterpenee | M. tuberculosis inhibition | Undetermined | GER | Konig et al., 2000 |
Antituberculosis | Elisapterosin B/soft coral | Diterpenee | M. tuberculosis inhibition | Undetermined | USA | Rodriguez et al., 2000 |
Antiviral | Cyclodidemniserinol trisulfate/ascidian | Polyketided | In vitro HIV infection inhibition | HIV-1 integrase inhibition | USA | Mitchell et al., 2000 |
Antiviral | Dragmacidin F/sponge | Alkaloidf | In vitro HSV-1 and HIV-1 inhibition | Undetermined | ITA | Cutignano et al., 2000 |
Antiviral | Lobohedleolide, 17-dimethylamino/soft coral | Diterpenee | In vitro HIV infection inhibition | Undetermined | USA | Rashid et al., 2000 |
Antiviral | Mololipids/sponge | Alkaloidf | In vitro HIV-1 infection inhibition | Undetermined | USA | Ross et al., 2000 |
Kingdom Animalia: brittle star and cucumber (phylum Echinodermata), clam and mussel (phylum Mollusca), sponge (phylum Porifera), tunicate (phylum Chordata). Kingdom Fungi: fungus; Kingdom Plantae: alga; Kingdom Monera: bacterium (phylum Cyanobacteria).
MMOA is molecular mechanism of action.
AUS is Australia; BRA, Brazil; GER, Germany; ITA, Italy; JPN, Japan; NETH, The Netherlands; NZ, NewZealand; SING, Singapore; SWE, Sweden; SWZ, Switzerland; UK, United Kingdom.
Polyketides;
Terpene;
Nitrogen-containing compound;
Polysaccharide.